RASSF1 and non-small cell lung carcinoma: In this study, we studied the abnormal gene methylation status of RASSF1A in NSCLC cell line A549 and anti-Cisplatin cell strain A549DDP and suggested that methyaltion of RASSF1A is a molecular biomarker in cancer diagnosis, treatment and prognosis.